Stock Events

Quest Diagnostics 

€131.8
157
+€2.35+1.82% Friday 06:05

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
15.6B
市盈率
18.53
股息收益率
2.09%
股息
2.75

即將到來

股息

2.09%股息收益率
10年增長
8.66%
5年增長率
6.9%
3年增長率
6.94%
1年增長率
6.09%

收益

23Jul確認
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
下一個
1.86
2.02
2.17
2.33
預期每股收益
2.33
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 QDI.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

150.89平均價格目標
最高估價為 €165。
來自過去 6 個月內的 9 個評級。這不是投資建議。
買入
33%
持有
67%
賣出
0%

關於

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Show more...
首席執行官
Mr. James E. Davis
員工
50000
國家
US
ISIN
US74834L1008
WKN
000904533

上市公司